Apheresis Market is Forecasted to Grow at a High Pace Owing to Increasing Blood Related Disorders

The Global Apheresis Market was valued at US$ 1,900.0 million in 2020, and it is expected to reach US$ 3,400.0 million by 2027, with a CAGR of 9.2%, during the forecast period, 2021 - 2027.

Rising applications of plasma therapy in various health issues is a key factor driving growth of the global apheresis market. These health issues include but not limited to severe rheumatoid arthritis, severe, vasculitis, systemic lupus, and in solid organ transplantation. Moreover, rising blood related diseases among the population all over the world is the propelling factor for the growth of the target market. Additionally, the growing demand for the blood plasma by different pharmaceutical companies is another driving factor for the growth of global market.

Apheresis plays a key role in the purification of the blood to prevent and control the kidney disorder is the fuelling factor for the growth of the target market. For instance, in 2019, in US, according to the Center of Control and Prevention(CDC) it is projected that the 15% adults i.e about 37 million adults are suffering from (CKD) chronic kidney disease. Moreover, the product approvals is another driving factor for the growth of the target market. For instance, Fresenius Kabi USA and Fresenius Kabi AG in June 2020, acknowledged FDA approval for system called as ALYX Component Collection System, this system is anticipated to segregate and collect blood into the components and anticipated for the setting up of the blood collection.

However, some factors such as myth about the procedure, chances of infection, and bleeding at donation site may hamper growth of the global market to a certain extent. The complication associated for the procedure of the apheresis is anticipated as the restraining the market growth.

Global Apheresis Market by Region Outlook (Revenue, USD Million, 2021-2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

In terms of geography, the North America region is the fastest growing region over the forecast period. Presence of developed blood collection facilities and high product penetration are driving the growth of the market. As increasing the blood donation camps and rising awareness about blood donation are the factor which propels the growth of the apheresis market in the North America region.  

The Global Apheresis Market Segmentation:

Global Apheresis Market by Product Type Outlook (Revenue, USD Million, 2021-2027)

  • Devices
  • Disposable & Reagents

Global Apheresis Market by Method Outlook (Revenue, USD Million, 2021-2027)

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

Global Apheresis Market by Procedure Outlook (Revenue, USD Million, 2021-2027)

  • Donor/Automated Apheresis
  • Therapeutic Apheresis

Global Apheresis Market by Component Outlook (Revenue, USD Million, 2021-2027)

  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis)
  • Lymphocytes (Lymph Apheresis)
  • Photopheresis
  • RBC's (Erythropheresis)

Global Apheresis Market by End-Users Outlook (Revenue, USD Million, 2021-2027)

  • Blood Centres
  • Hospitals
  • Other End Users

Apheresis Market Key Findings:

  • Based on the procedure, the therapeutic apheresis segment held the largest market share in 2020.
  • Based on product type, disposable & reagents accounted for a highest market share and followed by devices segment.
  • Based on regions, the North America region held the largest share of the market in 2020 and is expected to maintain it’s dominance during the forecast period.

Apheresis Market Company Profiles and Competitive Intelligence

The key players operating in the market are:

  • Fresenius Kabi
  • Kaneka Corporation
  • Haemonetics Corporation
  • Terumo BCT, Inc.
  • HemaCare Corporation
  • Asahi Kasei Medical Co., Ltd.
  • Kawasumi Laboratories Inc.
  • Nikkiso Co., Ltd.
  • Baxter International Inc.
  • Macopharma SA
  • B. Braun Melsungen AG 
  • Cerus Corporation
  • Mallinckrodt PLC
  • Otsuka Holdings Co. Ltd
  • Medica SPA
  • Fenwal, Inc.Therakos, Inc.

Apheresis Market Recent News:

  • In April 2017, myasthenia gravis (MG) and Guillain-Barré syndrome (GBS) is treated by using therapeutic plasma exchange which received CE making. For the Therapeutic plasma exchange the Terumo BCT launch the Spectra Optia apheresis system.
  • In January 2020, Fresenius Kabi expanded it’s transfusion and apheresis disposables plant by investing €30 Mn in Dominican Republic.

Quick Inquiry

Follow Us